Arcitumomab Biosimilar - Research Grade

Human

CEACAM5ï؟½

5mg/ml

Fab' - G1 - nd

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P06731

Blue ice

CEACAM5 (CEA) is a carcinoembryonic glycoprotein widely over-expressed in epithelial tumours and a classic antigen in oncology and tumour-imaging research. This recombinant anti-human CEACAM5 Fab' fragment is an unconjugated, non-therapeutic analog of arcitumomab, provided strictly for research use only. Built to demanding in vivo standards and low in endotoxin, it is manufactured in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. It serves as a dependable binding control and active reagent in antigen-targeting assays, in vitro functional screening, and in vivo oncology models, with consistent lot-to-lot performance.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks